Axon Enterprise, Inc. (NASDAQ:AXON) Receives $604.67 Consensus PT from Analysts

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) has received an average recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and ten have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $626.45.

AXON has been the subject of several recent research reports. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Barclays reissued a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th.

Axon Enterprise Stock Performance

Shares of AXON stock traded up $3.59 during mid-day trading on Thursday, reaching $578.42. 330,240 shares of the company's stock traded hands, compared to its average volume of 806,583. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $44.32 billion, a PE ratio of 149.46, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. Axon Enterprise has a 12 month low of $273.52 and a 12 month high of $715.99. The firm has a 50 day moving average price of $562.98 and a two-hundred day moving average price of $563.07.

Remove Ads

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 6.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AXON. Friedenthal Financial boosted its stake in Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company's stock valued at $808,000 after buying an additional 1,231 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company's stock valued at $54,466,000 after acquiring an additional 33,869 shares during the last quarter. Artemis Investment Management LLP grew its holdings in shares of Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company's stock valued at $56,528,000 after purchasing an additional 16,792 shares in the last quarter. Decker Retirement Planning Inc. purchased a new position in shares of Axon Enterprise in the fourth quarter valued at $2,985,000. Finally, Geode Capital Management LLC raised its stake in Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company's stock valued at $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.